164 related articles for article (PubMed ID: 22995065)
21. Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-Fc epsilon RI alpha-chain receptor antibody: implications for the involvement of the membrane-proximal alpha-chain region in Fc epsilon RI-mediated cell activation.
Nechansky A; Robertson MW; Albrecht BA; Apgar JR; Kricek F
J Immunol; 2001 May; 166(10):5979-90. PubMed ID: 11342613
[TBL] [Abstract][Full Text] [Related]
22. Mutagenesis within human FcepsilonRIalpha differentially affects human and murine IgE binding.
Mackay GA; Hulett MD; Cook JP; Trist HM; Henry AJ; McDonnell JM; Beavil AJ; Beavil RL; Sutton BJ; Hogarth PM; Gould HJ
J Immunol; 2002 Feb; 168(4):1787-95. PubMed ID: 11823511
[TBL] [Abstract][Full Text] [Related]
23. An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, nonreceptor binding conformation.
Wurzburg BA; Kim B; Tarchevskaya SS; Eggel A; Vogel M; Jardetzky TS
J Biol Chem; 2012 Oct; 287(43):36251-7. PubMed ID: 22948141
[TBL] [Abstract][Full Text] [Related]
24. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
[TBL] [Abstract][Full Text] [Related]
25. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system.
Newman M; Josiah S
J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339
[TBL] [Abstract][Full Text] [Related]
26. A General TR-FRET Assay Platform for High-Throughput Screening and Characterizing Inhibitors of Methyl-Lysine Reader Proteins.
Rectenwald JM; Hardy PB; Norris-Drouin JL; Cholensky SH; James LI; Frye SV; Pearce KH
SLAS Discov; 2019 Jul; 24(6):693-700. PubMed ID: 31017815
[TBL] [Abstract][Full Text] [Related]
27. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
Jabs F; Plum M; Laursen NS; Jensen RK; Mølgaard B; Miehe M; Mandolesi M; Rauber MM; Pfützner W; Jakob T; Möbs C; Andersen GR; Spillner E
Nat Commun; 2018 Jan; 9(1):7. PubMed ID: 29295972
[TBL] [Abstract][Full Text] [Related]
28. Repurposing a Histamine Detection Platform for High-Throughput Screening of Histidine Decarboxylase.
Juang YC; Fradera X; Han Y; Partridge AW
SLAS Discov; 2018 Oct; 23(9):974-981. PubMed ID: 29884090
[TBL] [Abstract][Full Text] [Related]
29. Identification of amino acid residues involved in the interaction of canine IgE with canine and human FcεRIα.
Ye H; Housden JE; Hunter M; Sabban S; Helm BA
Mol Immunol; 2014 Feb; 57(2):111-8. PubMed ID: 24084098
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence resonance energy transfer assay for high-throughput screening of ADAMTS1 inhibitors.
Peng J; Gong L; Si K; Bai X; Du G
Molecules; 2011 Dec; 16(12):10709-21. PubMed ID: 22186957
[TBL] [Abstract][Full Text] [Related]
31. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
[TBL] [Abstract][Full Text] [Related]
32. A novel screening method for competitive FRET-aptamers applied to E. coli assay development.
Bruno JG; Carrillo MP; Phillips T; Andrews CJ
J Fluoresc; 2010 Nov; 20(6):1211-23. PubMed ID: 20443050
[TBL] [Abstract][Full Text] [Related]
33. Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen.
Bunch TA; Guhathakurta P; Lepak VC; Thompson AR; Kanassatega RS; Wilson A; Thomas DD; Colson BA
J Biol Chem; 2021 Jul; 297(1):100840. PubMed ID: 34052227
[TBL] [Abstract][Full Text] [Related]
34. Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation.
Hermanson SB; Carlson CB; Riddle SM; Zhao J; Vogel KW; Nichols RJ; Bi K
PLoS One; 2012; 7(8):e43580. PubMed ID: 22952710
[TBL] [Abstract][Full Text] [Related]
35. Fine structure analysis of interaction of FcepsilonRI with IgE.
Hulett MD; Brinkworth RI; McKenzie IF; Hogarth PM
J Biol Chem; 1999 May; 274(19):13345-52. PubMed ID: 10224096
[TBL] [Abstract][Full Text] [Related]
36. Development of a Time-Resolved Fluorescence Resonance Energy Transfer ultra-high throughput screening assay for targeting SYK and FCER1G interaction.
Du Y; Wang D; Katis VL; Zoeller EL; Qui M; Levey AI; Gileadi O; ; Fu H
bioRxiv; 2024 Jun; ():. PubMed ID: 38915662
[TBL] [Abstract][Full Text] [Related]
37. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
[TBL] [Abstract][Full Text] [Related]
38. Time-resolved fluorescence resonance energy transfer kinase assays using physiological protein substrates: applications of terbium-fluorescein and terbium-green fluorescent protein fluorescence resonance energy transfer pairs.
Riddle SM; Vedvik KL; Hanson GT; Vogel KW
Anal Biochem; 2006 Sep; 356(1):108-16. PubMed ID: 16797477
[TBL] [Abstract][Full Text] [Related]
39. Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.
Zhang K; Liu J; Truong T; Zukin E; Chen W; Saxon A
J Immunol; 2017 May; 198(10):3823-3834. PubMed ID: 28396318
[TBL] [Abstract][Full Text] [Related]
40. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
